GCGlory Chidumwa

Glory Chidumwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Glory Chidumwa has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implementing wearable electronic devices to measure physiological effects of heat on pregnant women in Tshwane, South Africa: Lessons from the field (Preprint)

    by Celeste Charleneton Madondo, Shobna Sawry, Jean Le Roux, Glory Chidumwa, Lebohang Radebe, Pascalia Munyewende, Rose Refilwe Lamola, Otsile Lekabe, Nicholas Brink, Matthew Chersich, et al.

    BACKGROUND There is limited individual-level personalised data measuring the effect of heat exposure on health outcomes. While technologies that provide individual-level continuous, physiological, and behavioural metrics are increasingly available, their use in low- and middle-income countries (LMICs) remains limited, where the implementation of mHealth and wearable devices faces unique challenges. OBJECTIVE To describe experiences from implementing wearable devices to track heat exposure and key physiological parameters among pregnant and postpartum women in Tshwane, South Africa. METHODS Pregnant women (gestational age 30-36 weeks) were enrolled and trained on the use of a wearable Fitbit Inspire 3 activity tracking device worn on their wrist, with an iButton temperature monitor attached. Women were asked to wear the device daily, from enrolment up to six weeks postpartum; with data downloads every 4-6 days. The devices collected data periodically on ambient temperature, sleep, physical activity and heart rate. At study exit, women completed questionnaires about their experiences with the wearables. RESULTS Of 25 women enrolled, 64% lived in informal dwellings, 92% had iron sheet roofing, and 35% lacked access to electricity, necessitating frequent home visits by study staff to provide wearable charging via power banks. Internal storage on the FitBit device was limited to 7-days so data downloads were required every 4-6 days. Among 22 women who completed the study, time wearing the device for over four hours per day accounted for 37.0% overall during the study period but varied considerably between participants. Women reported feeling unsafe wearing the device (24%) and forgetting or not wearing it while doing daily chores (15%). Wear-time improved after engagement to encourage and support more regular use of the devices through additional counselling during study visits to download the data. Women reported the wearables increased awareness of their activity levels, motivating them be more active. CONCLUSIONS The study describes our experiences with wearable devices use among pregnant women predominantly living in informal settlements with limited access to basic services and poor dwelling infrastructure. The influence of access to physiological parameters and its impact on personal activity has not been previously reported in this population. Despite high cellphone penetration, which can facilitate the use of mHealth technologies, significant implementation challenges remain in terms of access to smartphones to sync data, electricity supply, user safety concerns, and data completeness.

  • Open Access

    Characterizing HIV seroconversions among a cohort of oral PrEP users in South Africa

    by Catherine E. Martin, Hlologelo Ramatsoma, Glory Chidumwa, Laura Ashleigh Cox, Saiqa Mullick

    Introduction: There has been significant progress in the rollout of oral pre‐exposure prophylaxis (PrEP) for the prevention of HIV. The introduction of long‐acting prevention methods holds the potential to improve HIV prevention uptake and use, however, presents unique complexities regarding HIV diagnosis and potential for resistance. Quantifying and understanding the scenarios within which seroconversions occur may help to inform approaches to identifying acute HIV in programmes delivering PrEP at scale. Methods: This paper documents ctra series of seroconversions within a large implementation study conducted in eight Department of Health facilities and four linked mobile clinics in four areas of South Africa. Using routinely collected data, we conducted a descriptive analysis of clients who seroconverted after initiating oral PrEP and determined the distribution of time from oral PrEP initiation to seroconversion as well as the proportion of days covered by oral PrEP. A seroconversion was defined as any HIV‐positive diagnosis after initiation of PrEP. Time to seroconversion was calculated as the number of days between the first PrEP initiation and the date of HIV diagnosis. The proportion of days covered by PrEP was calculated as the number of days of PrEP prescribed over the number of days between PrEP initiation and HIV seroconversion. We conducted a logistic regression to determine factors associated with seroconversion. Results: Of the 11,882 clients initiated on PrEP between January 2019 and October 2022 who attended at least one follow‐up visit, 112 (0.9%) seroconverted after PrEP initiation. Among those who seroconverted, the median proportion of days covered by PrEP between initiation and seroconversion was 33%. In the period between PrEP initiation and seroconversion, almost all ( n = 93, 83.0%) had not used PrEP consistently, with only 19 (17.0%) having consistent PrEP use, all of whom were identified at the 1‐month follow‐up visit and were likely missed acute acquisitions. Younger age and geographical area were associated with seroconversion. Conclusions: This study reports a low number of seroconversions among a large cohort of PrEP users in a real‐world implementation study, the majority of which occurred among clients who had interrupted or discontinued PrEP use.


  • Making sense of regression models in clinical research: a guide to interpreting beta coefficients and odds ratios

    by Okechinyere Juliet Achilonu, Nneamaka O. Echendu, Glory Chidumwa

    Regression models play a central role in clinical research by quantifying the relationship between outcomes and explanatory variables. Accurate interpretation of model outputs, such as beta coefficients in linear regression and odds ratios in logistic regression, is critical for drawing valid conclusions. This article focuses on the key principles for interpreting linear and logistic regression results in clinical research. A publicly available heart disease dataset was used to demonstrate this. Linear regression was applied to a continuous outcome (cholesterol), while logistic regression modelled a binary outcome (presence of heart disease). Model building involved purposeful variable selection to account for confounding. Model adequacy and multicollinearity were assessed using goodness-of-fit statistics and variance inflation factors, respectively. Interpretation of results focused on beta coefficients and odds ratios. Regression models are robust methods for analysing clinical data and identifying key predictors. The concepts presented in this manuscript provide a foundational framework for applying and understanding linear and logistic regression in clinical research.

  • Open Access

    Preferences for Delivery of HIV Prevention Services Among Healthcare Users in South Africa: A Discrete Choice Experiment

    by Catherine Elizabeth Martin, Duane Blaauw, Pelisa Nongena, Glory Chidumwa, Siphokazi Dada, Samantha Jack, Vusile Butler, Saiqa Mullick

    Progress has been made to scale oral pre-exposure prophylaxis (PrEP) as part of combination HIV prevention, with the WHO recommending differentiated, simplified and demedicalized approaches. This study explored user preferences for components of a PrEP service delivery package, through a discrete choice experiment (DCE) among 307 people accessing primary healthcare services in South Africa between November 2022 and February 2023. Attributes included were: Source of information about HIV prevention and PrEP; Site for PrEP initiation and follow-up; Frequency of follow-up; PrEP pick-up point; HIV testing whilst using PrEP; Contact between appointments. A D-efficient DCE design was created with 16 choice sets in 2 blocks. DCE data were analysed using generalised multinomial logistic models. Compared to printed materials, participants preferred getting information about PrEP online (aOR = 7.73, 95% CI = 5.13–11.66) and through WhatsApp (aOR = 2.23, 95% CI = 0.98–5.55). PrEP initiation at a pharmacy or mobile clinic was valued equally to initiating PrEP at a clinic, but a community pop-up site was less preferred (aOR = 0.46, 95% CI = 0.33–0.64). There was a preference for 6-monthly over 3-monthly follow-up (aOR = 11.88, 95% CI = 5.44–25.94). Participants preferred collecting PrEP from a pharmacy (aOR = 5.02, 95% CI = 3.45–7.31), through home delivery (aOR = 2.18, 95% CI = 1.26–3.78) and from a vending machine (aOR = 1.43, 95% CI = 1.02–1.99) relative to where they initiated PrEP. Participants also preferred HIV self-testing over a healthcare provider test (aOR = 5.57, 95% CI = 3.72, 8.36). WhatsApp or Facebook groups (aOR = 4.12, 95% CI = 3.00–5.67), monthly phone calls (aOR = 2.84, 95% CI = 1.73–4.67) and weekly messages (aOR = 1.47, 95% CI = 1.10–1.97) were preferred contact between appointments, relative to no contact. To meet users’ preferences, there is a need to expand decentralised and self-led HIV prevention services.


  • Open Access

    HIV, hypertension and diabetes care and all-cause mortality in rural South Africa in the HIV antiretroviral therapy era: a longitudinal cohort study

    by Glory Chidumwa, Lusanda Mazibuko, Stephen Olivier, Kashfia Rahman, Dickman Gareta, Taing N Aung, Jacob Busang, Kobus Herbst, Emily Wong, Kathy Baisley, et al.

    Introduction South Africa is in the midst of rapid epidemiological transition from extremely high HIV and tuberculosis (TB) mortality to one characterised increasingly non-communicable disease-related deaths. However, longitudinal data linking modifiable risk factors and disease care indices to mortality in the country are extremely rare, and a prerequisite to appropriately prioritise health system responses. Methods Individuals in the Africa Health Research Institute Southern Demographic Health Surveillance area were invited to health fairs to collect data on modifiable risk factors and HIV, TB, diabetes and hypertension disease status and control. Individuals are then followed longitudinally through routine surveillance to detect deaths. We fit Cox proportional hazards models and estimated population-attributable fractions (PAFs) to identify modifiable risk factors and disease control indicators associated with all-cause mortality. Results A total of 18 041 individuals completed health screening and were followed for 114 692 person-years. Men had higher mortality rates than women across all age bands. The median follow-up time was 3.3 years (IQR: 3.0–3.5 years). For men, communicable diseases accounted for a higher PAF of mortality (PAF=13.7% for HIV and 8.3% for TB) than non-communicable diseases (6.6% for hypertension and 1.9% for diabetes). By contrast, despite extremely high HIV prevalence, non-communicable diseases with comorbid communicable disease accounted for the greatest share of deaths. In both sexes, having a chronic disease with poor control was most predictive of all-cause mortality. For example, among men, compared with those without each condition, adjusted HRs of all-cause mortality for people with uncontrolled disease were 3.47 (95% CI 2.10 to 5.72) for HIV, 1.52 (95% CI 1.05 to 2.20) for hypertension and 2.34 (95% CI 1.75 to 6.79) for diabetes. Among women, these same ratios were 5.32 (95% CI 3.54 to 7.99) for HIV, 1.73 (95% CI 1.31 to 2.28) for hypertension and 3.11 (95% CI 2.02 to 4.77) for diabetes. Discussion Poor control of chronic, treatable diseases predicts all-cause mortality in rural South Africa in the HIV antiretroviral therapy era. Health system strengthening to improve chronic disease and multimorbidity care should be prioritised.


  • Open Access

    Prevalence of Curable Sexually Transmitted Infections in a Population-Representative Sample of Young Adults in a High HIV Incidence Area in South Africa

    by Jana Jarolimova, Glory Chidumwa, Natsayi Chimbindi, Nonhlanhla Bsn Okesola, Jaco NDipIT Dreyer, Theresa Smit, Janet Seeley, Guy ScD Harling, Andrew Copas, Kathy Msc Baisley, et al.

    Background: Recent population-representative estimates of sexually transmitted infection (STI) prevalence in high HIV burden areas in southern Africa are limited. We estimated the prevalence and associated factors of 3 STIs among adolescents and young adults (AYA) in rural South Africa. Methods: Between March 2020 and May 2021, a population-representative sample of AYA aged 16 to 29 years were randomly selected from a Health and Demographic Surveillance Site in rural KwaZulu-Natal, South Africa, for a 2 × 2 factorial randomized controlled trial. Participants in 2 intervention arms were offered baseline testing for gonorrhea, chlamydia, and trichomoniasis using GeneXpert. Prevalence estimates were weighted for participation bias, and logistic regression models were used to assess factors associated with STIs. Results: Of 2323 eligible AYA, 1743 (75%) enrolled in the trial. Among 863 eligible for STI testing, 814 (94%) provided specimens (median age of 21.8 years, 52% female, and 71% residing in rural areas). Population-weighted prevalence estimates were 5.0% (95% confidence interval [CI], 4.2%–5.8%) for gonorrhea, 17.9% (16.5%–19.3%) for chlamydia, 5.4% (4.6%–6.3%) for trichomoniasis, and 23.7% (22.2%–25.3%) for any STI. In multivariable models, female sex (adjusted odds ratio [aOR], 2.24; 95% CI, 1.48–3.09) and urban/periurban (vs. rural) residence (aOR, 1.48; 95% CI, 1.02–2.15) were associated with STIs; recent migration was associated with lower odds of STI (aOR, 0.37; 95% CI, 0.15–0.89). Among those with an STI, 53 (31.0%) were treated within 7 days; median time to treatment was 11 days (interquartile range, 6–77 days). Conclusions: We identified a high prevalence of curable STIs among AYA in rural South Africa. Improved access to STI testing to enable etiologic diagnosis and rapid treatment is needed.


  • Open Access

    Direct and Indirect Determinants of Body Mass Index in Both Major Ethnic Groups Experiencing the Nutritional Transition in Cameroon

    by Emmanuel Cohen, Norbert Amougou, Amandine Ponty, Margaux Guerrien, Wakilongo Wakenge, Glory Chidumwa, Rihlat Said-Mohamed, Léopold K. Fezeu, Patrick Pasquet

    In the context of rapid nutritional transitions in Africa, few studies have analyzed the etiology of obesity by considering the driver pathways that predict body mass index (BMI). The aim of this study is to innovatively identify these driver pathways, including the main sociodemographic and socioecological drivers of BMI. We conducted a rural–urban quantitative study in Cameroon (n = 1106; balanced sex ratio) to explore this issue. We recruited participants and reported several sociodemographic characteristics (e.g., marital status, socioeconomic status (SES), and ethnicity). We then assessed three main socioecological drivers of BMI (body weight perception, dietary intake, and physical activity) and conducted bioanthropometric measurements. We identified several driver pathways predicting BMI. In Cameroon, Bamiléké ethnicity, higher SES, being married, and older age had positive effects on BMI through overweight valorization and/or dietary intake. Accordingly, we found that being Bamiléké, married, and middle-aged, as well as having a higher SES, were factors that constituted at-risk subgroups overexposed to drivers of obesity. As such, this study highlights the necessity of investigating the complex driver pathways that lead to obesity. Therefore, better identification of the subgroups at risk for obesity will help in developing more targeted population health policies in countries where this burden is a major public health issue.


  • Open Access

    Obesity and adiposity of 3- to 6-year-old children born to mothers with hyperglycaemia first detected in pregnancy in an urban South African setting

    by Larske M. Soepnel, Veronique Nicolaou, Christine Slater, Glory Chidumwa, Naomi S. Levitt, Kerstin Klipstein-Grobusch, Shane A. Norris

    Understanding the association between maternal metabolic conditions in pregnancy and the risk of childhood overweight, a growing concern in sub-Saharan Africa (SSA), helps to identify opportunities...


  • Open Access

    Identifying co-occurrence and clustering of chronic diseases using latent class analysis: cross-sectional findings from SAGE South Africa Wave 2

    by Glory Chidumwa, Innocent Maposa, Barbara Corso, Nadia Minicuci, Paul Kowal, Lisa K Micklesfield, Lisa Jayne Ware

    Objectives To classify South African adults with chronic health conditions for multimorbidity (MM) risk, and to determine sociodemographic, anthropometric and behavioural factors associated with identified patterns of MM, using data from the WHO’s Study on global AGEing and adult health South Africa Wave 2. Design Nationally representative (for ≥50-year-old adults) cross-sectional study. Setting Adults in South Africa between 2014 and 2015. Participants 1967 individuals (men: 623 and women: 1344) aged ≥45 years for whom data on all seven health conditions and socioeconomic, demographic, behavioural, and anthropological information were available. Measures MM latent classes. Results The prevalence of MM (coexistence of two or more non-communicable diseases (NCDs)) was 21%. The latent class analysis identified three groups namely: minimal MM risk (83%), concordant (hypertension and diabetes) MM (11%) and discordant (angina, asthma, chronic lung disease, arthritis and depression) MM (6%). Using the minimal MM risk group as the reference, female (relative risk ratio (RRR)=4.57; 95% CI (1.64 to 12.75); p =0.004) and older (RRR=1.08; 95% CI (1.04 to 1.12); pConclusion NCDs with similar pathophysiological risk profiles tend to cluster together in older people. Risk factors for MM in South African adults include sex, age and tobacco use.


  • Open Access

    Determinants of change in blood pressure in Ghana: Longitudinal data from WHO-SAGE Waves 1–3

    by Elias K. Menyanu, Barbara Corso, Nadia Minicuci, Ilaria Rocco, Joanna C. Russell, Lisa J. Ware, Glory Chidumwa, Nirmala N. Naidoo, Richard B. Biritwum, Paul R. Kowal, et al.

    The prevalence of hypertension is increasing in low- and middle-income countries, however statistics are generally derived from cross sectional surveys that utilize different methodologies and population samples. We investigated blood pressure (BP) changes over 11–12 years in a large cohort of adults aged 50 years and older (n = 820) included in the World Health Organization’s Study on global AGEing and adult health (WHO-SAGE Ghana) Wave 1 (2007/8) with follow up in Wave 3 (2019). Participants’ BP were measured in triplicate and a survey completed at both time points. Survey instruments collected information on sociodemographic characteristics, lifestyle, health behaviors and chronic conditions. While no significant difference was found in systolic BP between Waves 1 and 3, diastolic BP decreased by 9.7mmHg (mean = 88.6, 15.4 to 78.9, 13.6 respectively) and pulse pressure increased by 9.5mmHg (44.8, 13.7 to 54.3, 14.1). Awareness of hypertension increased by 37%, from (20% to 57%), but no differences were found for the proportion of hypertensives receiving treatment nor those that had controlled BP. Mixed effects modelling showed a decrease in diastolic BP was associated with increasing age, living in rural areas and having health insurance. Factors associated with an increased awareness of hypertension were residing in urban areas, having health insurance and increasing body mass index. While diagnosis of hypertension has improved over time in Ghana, there is an ongoing need to improve its treatment in older adults.